Clinical Trials Browser

Not yet recruiting × vedolizumab × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

NCT06337695 2024-04-02

VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer

Phase 2/3 Not yet recruiting

Neoplasm Metastasis, Neoplasms